Sign In
Buy BNTX
$90.58
-2.27 (-2.44%)
At Close: Jul 31, 2026
BioNTech: The Market Is Offering A 17-Program Oncology Pipeline For Almost Free
05:48pm, Friday, 31'st Jul 2026
BioNTech trades near cash value, implying its advanced oncology pipeline is valued at nearly zero—an opportunity I rate as BUY. BNTX's €16.8B liquidity, $1B buyback, and cost restructuring enable
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
04:30pm, Wednesday, 29'th Jul 2026
Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages More than five billion dos
BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring
06:30pm, Thursday, 23'rd Jul 2026
BioNTech's oncology pipeline could help it make a dent in this large and growing market. However, there is one thing investors should consider before initiating a position.
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
06:45am, Tuesday, 21'st Jul 2026
MAINZ, Germany, July 21 , 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2026 on Tuesday, August
BioNTech SE Sponsored ADR $BNTX Shares Sold by Baader Bank Aktiengesellschaft
04:29am, Tuesday, 21'st Jul 2026
Baader Bank Aktiengesellschaft lowered its stake in BioNTech SE Sponsored ADR (NASDAQ: BNTX) by 10.4% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 136,425
Amova Asset Management Americas Inc. Invests $6.91 Million in BioNTech SE Sponsored ADR $BNTX
03:17am, Tuesday, 21'st Jul 2026
Amova Asset Management Americas Inc. acquired a new position in shares of BioNTech SE Sponsored ADR (NASDAQ: BNTX) in the undefined quarter, according to its most recent filing with the Securities and
Cathie Wood's Ark Invest Sold $7.4 Million of BioNTech Stock
09:42am, Tuesday, 14'th Jul 2026
On July 8, the Ark Genomic Revolution ETF sold roughly $7.4 million worth of BioNTech stock. Cathie Wood's ETF has now almost completely sold its entire position in BioNTech.
2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now
06:30pm, Tuesday, 07'th Jul 2026
They may not remain cheap for too much longer.
BioNTech held buyer talks over four German sites set to close, Handelsblatt reports
01:51am, Friday, 03'rd Jul 2026
BioNTech has held confidential talks with potential buyers about the German sites that the COVID‑19 vaccine maker plans to close, which has now grown to four locations, the Handelsblatt new
Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO
02:38am, Wednesday, 17'th Jun 2026
U.S. pharmaceutical company Moderna is interested in investing in production facilities in Germany, with an eye on plants that its German rival BioNTech plans to close, CEO Stepha
Arcus, Bristol Myers Team Up to Advance Kidney Cancer Study
12:55pm, Thursday, 04'th Jun 2026
Arcus Biosciences teams up with Bristol Myers Squibb to test casdatifan combinations in kidney cancer, expanding its ccRCC development strategy.
Bristol Myers Showcases Data on MM and NSCLC Drugs at ASCO
11:01am, Monday, 01'st Jun 2026
BMY unveils strong ASCO data for mezigdomide and pumitamig, highlighting late-stage pipeline progress across myeloma and lung cancer.
First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with chemotherapy in first-line non-small cell lung cancer acros
BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting
05:00am, Friday, 22'nd May 2026
Pumitamig data from the ongoing Phase 2/3 ROSETTA Lung-02 trial in first-line non-small cell lung cancer mark the third global data set to consistently show encouraging anti-tumor activity for pumitam
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026
04:15pm, Friday, 15'th May 2026
MAINZ, Germany, May 15, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) held its Annual General Meeting (“AGM”) today. A total of 92 per cent of the shar
